Status:
COMPLETED
The Medicines Optimisation Review Toolkit Evaluation in HIV Outpatients
Lead Sponsor:
Brighton and Sussex University Hospitals NHS Trust
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
HIV-1-infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Multicentre, randomised (1:1), controlled, open (not blinded) comparison of MOR toolkit (intervention) with standard pharmaceutical care (control)
Detailed Description
The aim of this study is to evaluate the utility, acceptability and feasibility of incorporating pharmacist Medicines Optimisation Reviews (MORs) into routine HIV outpatient care. Medicines reviews ar...
Eligibility Criteria
Inclusion
- Patients currently receiving cART who are ≥50 years old
- Patients \<50 years old who are currently receiving cART and have documented comorbidities in the medical notes or the UKCHIC database that may require treatment with medicines.
Exclusion
- Patients who have had a MOR conducted by an HIV pharmacist using the proposed tool within the previous 6 months
- Patients \< 18 years old
Key Trial Info
Start Date :
February 6 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03340077
Start Date
February 6 2018
End Date
December 31 2019
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brighton & Sussex University Hospitals NHS Trust
Brighton, East Sussex, United Kingdom, BN2 5BE